In Europe, cefiderocol is commercially available under the brand name Fetcroja® for the treatment of infections due to aerobic Gram-negative organisms in adults with limited treatment options.
13 In the U.S., cefiderocol is available under the brand name Fetroja® and is indicated in patients 18 years of age or older for the treatment of hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia (HABP/VABP) and complicated urinary tract infections (cUTIs) caused by certain susceptible Gram-negative microorganisms.
14 In Japan, cefiderocol is commercially available under the brand name Fetroja® and
received manufacturing and marketing approval from the Ministry of Health, Labour and Welfare for various infections caused by strains resistant to carbapenem antibiotics among sensitive strains of
Escherichia coli, Citrobacter species, Klebsiella pneumoniae, Enterobacter species
, Serratia marcescens, Proteus species
, Morganella morganii, Pseudomonas aeruginosa, Burkholderia species
, Stenotrophomonas maltophilia, and
Acinetobacter species.